Cite
HARVARD Citation
He, L. et al. (2020). Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors. American journal of clinical oncology. p. . [Online].